Clinical Trials Directory

Trials / Unknown

UnknownNCT06318065

Surgical Resection Outcomes in Patients With Brain Metastasis

Prognostic Factors Impacting Surgical Resection Outcomes in Patients With Brain

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
National Cheng-Kung University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

While many studies have investigated the prognostic factors for patients undergoing surgical resection for primary brain tumors, decision-making for patients with brain metastasis (BM) is more complex because of their higher burden of comorbidities compared to those with primary brain tumors. In addition, although various prognostic indicators have been identified to predict prognosis in several types of cancer, such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), prognostic nutritional index (PNI), and systemic immune-inflammation index (SII), limited studies have yet determined which group of patients would yield beater survival outcome after surgical resection for BM. This study aimed to investigate the impact of patient and perioperative characteristics and prognostic indicators on survival outcome of patients undergoing surgical resection of BM.

Conditions

Timeline

Start date
2010-01-01
Primary completion
2024-06-01
Completion
2024-09-01
First posted
2024-03-19
Last updated
2024-03-22

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06318065. Inclusion in this directory is not an endorsement.